|This comprehensive SWOT profile of Zynex Inc provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.|
This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Zynex Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
|Zynex Inc (Zynex), formerly Zynex Medical Inc is a medical equipment provider that manufactures and markets diagnostic products. The company offers medical devices through medical, monitoring solutions, and neurodiagnostics. Its products comprise NexWave, TruWave TENS, ValuTENS, Interferential Current, E-Wave Muscle Stimulator, NeuroMove NM900 and PGS-123 Pulsed-Galvanic Stimulator. Zynex manufactures electrotherapy products for home use, products for cardiac monitoring for use in hospitals, devices for EMG and EEG diagnostic purposes in the neurology clinical market. The company's products are used for patients suffering from impaired mobility due to stroke, spinal cord injury, and debilitating and chronic pain. Zynex is headquartered in Lone Tree, Colorado, the US.|
Zynex Inc Key Recent Developments
Jul 06,2017: Zynex Pays Off Loan Balance
Jun 09,2017: Zynex Hires Chief Financial Officer
May 15,2017: Zynex Announces 2017 First Quarter Results
Apr 03,2017: Zynex Announces 2016 Year End Results
Dec 29,2016: Zynex General Update and November Orders
Other reports that may be of interest...
Report Source Information
|Supplied by: Research and Experts|
|Date Published: 2017-08-07|
Report: Zynex Inc (ZYXI) - Financial and Strategic SWOT Analysis Review
| Table of Contents|
Section 1 - About the Company
Zynex Inc - Key Information
Zynex Inc - Overview
Zynex Inc - Key Employees
Zynex Inc - Key Employee Biographies
Zynex Inc - Key Operational Heads
Zynex Inc - Major Products and Services
Zynex Inc - History
Zynex Inc - Company Statement
Zynex Inc - Locations And Subsidiaries
Zynex Inc - Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 - Company Analysis
Zynex Inc - Business Description
Zynex Inc - Corporate Strategy
Zynex Inc - SWOT Analysis
SWOT Analysis - Overview
Zynex Inc - Strengths
Zynex Inc - Weaknesses
Zynex Inc - Opportunities
Zynex Inc - Threats
Zynex Inc - Key Competitors
Section 3 - Company Financial Performance Charts
Zynex Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
| List of Tables|
Zynex Inc, Key Information
Zynex Inc, Key Ratios
Zynex Inc, Share Data
Zynex Inc, Major Products and Services
Zynex Inc, History
Zynex Inc, Key Employees
Zynex Inc, Key Employee Biographies
Zynex Inc, Key Operational Heads
Zynex Inc, Other Locations
Zynex Inc, Subsidiaries
Zynex Inc, Key Manufacturing facilities
Zynex Inc, Key Competitors
Zynex Inc, SWOT Analysis
Zynex Inc, Ratios based on current share price
Zynex Inc, Annual Ratios
Zynex Inc, Interim Ratios
Capital Market Ratios
List of Figures
| List of Figures|
Zynex Inc, Performance Chart
Zynex Inc, Ratio Charts
The profile contains critical company information including*,
|Language Code: EN|
|Region: United States|
|Report Type: Company Reports|
|Industry: Life Sciences|
|Sector: Life Sciences|
Reasons to buy this report
|Key benefits of buying this profile include,|
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Other reports that may be of interest...
Zynex Inc (ZYXI) - Financial and Strategic SWOT Analysis Review
The Research and Experts relevance ranting consists of a set of figure of merit (FOM) values that are provided as an indication of the value of the report in the current economic environment.
These FOM values cannot take into account the reason for the clients interest in a report and therefore the client should view these FOM values only as a visual guide. The FOM scores are based on
market interest - how often the report is viewed or purchased,
Branch ID: 1555
The taxonomy on the left shows the ancestors of the United States node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.
The US has the largest economy in the world. It is highly industrialised and some of the main industries include; petroleum, steel, motor vehicles, aerospace, telecommunications, chemicals, electronics, food processing, consumer goods, lumber and mining.
The US economy is dealing with slow growth rates, unemployment and increasing national debt since the recession of 2008/2009 however economists expect much higher growth in the US economy in 2014. The IMF expects growth to increase from 1.9% in 2013 to 2.8% in 2014. The IMF expects a drop in unemployment to 6% in 2014. The indicators are good. The private sector is growing, federal spending will continue and some of the underlying drags on the economy are diminishing. Cheaper energy coming from increased oil exploration, gas fracking and renewables has helped to bring more jobs back to the US. The manufacturing sector is growing again and manufacturing technology is improving.
There is a shortage of housing as a result of limited construction in recent years. Satisfying this demand should provide a much needed boost for the construction industry. There has also been considerable under investment in many other areas of the economy during the credit crunch and it is expected that there will be growth in the IT sector as companies carry out much needed upgrading of systems.
Inequality is a major issue in the US economy. More of the wealth is going to the top 1% of high earners and middle incomes are stagnant. Tax reform is necessary for the redistribution of wealth. By putting more money in the pockets of the lower and middle classes the US economy will start to see some real growth.
Researchandexperts.com is a leading source of market research on key industry sectors in the USA.
The term North America usually refers to the US and Canada sometimes including Geenland, Mexico and the islands of Bermuda, St Helena and Saint Pierre et Miquelon.
North America is dominated by the largest global economy, the United States. The main industries in the US are technology, petroleum, steel, motor vehicles, aerospace, telecommunications, chemicals, electronics, food processing, consumer goods, lumber and mining. The US main tading partners are Canada, China, Mexico, Japan, and Germany. Canada is one of the largest economies in the world and is listed as one of the G8. Canada has a well established services sector along with well established industries in the areas of maufacturing, mining and logging. Canada's main trading partners are US, EU, China and Mexico.
Research and Experts, the market intelligence platform, provides companies with access to the latest leading industry reports covering the North American region. Our company reports contain the following information; company overviews, key facts, key employees, products and services, as well as financial ratios. Our industry reports are vital sources of detailed historic and forecast values for markets in North America, segmented at category level.
Research and Experts reports also provide regional analysis and analysis of the leading companies in key North American markets. Researchandexperts.com is a leading source of market research on North America.
Branch ID: 205
The taxonomy on the left shows the ancestors of the Life Sciences node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.
The Life Sciences industry includes biotechnology, healthcare, pharmaceuticals, medical devices and diagnostics. The industry is dominated by US companies requiring considerable investment in research and development to stay competitive. While US companies dominate this space, competition is emerging from smaller companies in Europe and Asia.
Companies trying to stay competitive or enter new markets in life sciences consult our reports. For example, Plimsoll, in their recent review of global antibiotic manufacturers have reviewed 150 of the largest manufacturers including analysis of ANTIBIOTICE SA, BAYER HEALTHCARE MANUFACTURING SRL and CIPLA LTD.
Our reports are a requirement for companies looking for the best competitive intelligence in the life sciences sector providing information on market size, rankings, best trading partners and financial analysis.
Buy: Zynex Inc (ZYXI) - Financial and Strategic SWOT Analysis Review
Item Code: 05IC-GDPH34280FSA
|Licence: Single User|
Page created and rendered - Cache updated [1.69733s]